Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0027651 (tumor)
 685,946 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

We have conducted a correlative histological and clinical study on 34 cases of childhood ependymomas encountered at the Children's Memorial Hospital from 1953 to 1974. The cases were classified into grades A, B and C according to the extent of cytological differentiation and the correlation between the histological grades and the clinical outcome was obtained. It is concluded that the biological behavior of an ependymoma could be predicted to a large extent by the degree of cytological differentiation and by its anatomical location. A large share of the infratentorial ependymomas are well differentiated (grade A) and prognosis in this group is good when complete surgical removal could be accomplished. Most of the supratentorial ependymomas belong to the intermediate grade B and the malignant grade C; prognosis in these two grades is less predictable, approximately two thirds of these patients died within 3 years. The most malignant form is the ependymoblastoma. This is a highly primitive neoplasm histologically similar to medulloblastoma but shows evidence of ependymal differentiation. Most of the ependymoblastomas are located in the supratentorial region and the average length of survival is 20 months.
 ...
PMID:Ependymomas of childhood. I. Histological survey and clinicopathological correlation. 97 35

Clinical and neuropathological findings in monozygous twin sisters are reported. Twin I died at age 5 months from a cerebellar medulloblastoma, whereas her sister died at age 16 months from a pineoblastoma. The tumors are considered similar referring to histogenesis, structural peculiarities and growth. Therefore, the twins are seen as concordant for the tumor type.
 ...
PMID:[Medulloblastoma and pineoblastoma in monozygous twins (author's transl)]. 98 28

On the base of 77 medulloblastomas of the cerebellum, it is a point out the actual management of children with medulloblastoma which can be summed up as a combination of surgery to relieve pressure and remove as much of the tumor as possible, para-operative vincristine, radical treatment of the whole C.N.S. by radiotherapy followed by maintenance chemotherapy of B.C.N.U. and vincristine.
 ...
PMID:Medulloblastoma of the cerebellum. 101 95

The fine structure of a primary intracranial lymphoma was examined and compared with that of a group of central nervous system tumors comprised of medulloblastoma, oligodendroglioma, ependymoma, ependymoblastoma. The principal difference was the absence of any junctional devices on the principal tumor cells of the lymphoma and their presence in the other tumors. It is suggested that this difference reflects the difference in origin of these tumors.
 ...
PMID:A comparison of the fine structure of malignant lymphoma and other neoplasms in the brain. 105 47

Radioisotope scanning with 99mTc-pertechnetate or 67Ga-citrate for the spinal cord tumors was reported. Six patients with spinal cord tumors including 2 ependymomas, 1 neurinoma, 1 metastatic medulloblastoma, 1 metastatic astrocytoma, and 1 metastatic pinealoma as well as 6 patients with non-neoplastic lesions were examined with this method. Two out of 6 cases with tumors showed positive scans and two equivocal scans. This new method is different from myeloscintigraphy and radioisotope angiography as already reported. It directly demonstrates tumor itself like brain scanning and is very useful as nontraumatic method for screening spinal cord lesions, especially in poor risk patient. The usefulness and limitation of this method are discussed.
 ...
PMID:Radioisotope scanning for the spinal cord tumor. 106 84

Immune deficiency of immunocompetent cells or of humoral factors are essential causes of tumor growth. The authors have investigated the transfer of immunocompetent cells - allogeneic bone marrow cell transfusion and white blood cell intracranial infusion - for the treatment of 11 malignant gliomas in infants and children as an adjuvant to surgery, radiation and/or chemotherapy. Ten cases, from 3 months to 11 years, received bone marrow cell transfusion. Two medulloblastomas and 3 pontine gliomas are dead. Five cases are alive and well 37-65 months following surgery. Among these two posterior fossa neoplasms, a medulloblastoma and a glioblastoma have survived 46 and 65 months, respectively. One cerebral glioblastoma received allogeneic white blood cells infused locally into the tumor bed: it recurred 1 year following surgery, chemotherapy, and immunotherapy. Cytolysis of the tumor cells by sensitized lymphoid cells were demonstrated in this case. The role of immunotherapy should be limited at the present time to adjuvant therapy until its effect on tumor growth is statistically confirmed. The results so far are promising, and improvement of the immunological approach in treating malignant brain tumors is under way.
 ...
PMID:Adjuvant immunotherapy for malignant brain tumors in infants and children. 110 67

Numerous investigators have reported on a variety of chemotherapeutic agents tested in children suffering from recurrent medulloblastoma, brain stem glioma, and ependymoma, in efforts to improve survival and reduce morbidity. Evaluation of such studies is difficult, because there were rarely more than three or four cases of each tumor type. In medulloblastoma, 5-year survival averages 32%; recurrence follows initial therapy by months to years. The recurrence may be intracranial, spinal, or metastatic, making comparison among cases very difficult. Intrathecal methotrexate (MTX) has been successfully used to treat medulloblastoma, with responses reported in about three-fourths of the cases. Intraventricular MTX is lethal when ventricular obstruction is present. MTX has been less useful in therapy of brain stem glioma and ependymoma. BCNU and CCNU have produced responses in patients with ependymoma, medulloblastoma, and brain stem glioma. Vincristine, alone or in combination, has been useful primarily in medulloblastomas. Less experience is available with several newer methods of chemotherapy, but promising results have been reported with procarbazine, 4'-demethyl-epipodophyllotoxin-beta-D-thenylidine-glucosede (PTG, VM 26), and high dose intravenous methotrexate with citrovorum rescue. It is likely that only a nationwide cooperative effort will achieve significant improvement in the chemotherapy of malignant brain tumors in children.
 ...
PMID:Chemotherapy of primary malignant brain tumors in children. 111 55

The occurrence of medulloblastoma in two brothers is presented. The striking similarities between two cases in the sex, age of onset of symptoms, clinical manifestations and histological findings suggested a possible role of heredity in the etiology of this tumor.
 ...
PMID:Medulloblastoma in two brothers. 116 94

A Developmental Gerstmann syndrome in a 7 years-old-boy with hyperactivity, short attention span, acalculia, agraphia, right-left confusion, finger agnosia and constructional apraxia is reported. An initial trial with methylphenidate was done with good improvement regarding hyperactivity, attention span and constructional apraxia. In the clinical course developed a cerebellar syndrome and intracranial hypertension. Surgical exploration of the cerebellum discovered a medulloblastoma. The author believes that this is the first described association of Developmental Gerstmann syndrome and cerebellar neoplasia. The clinical findings, the etiology and the topography of the Gerstmann syndrome are discussed.
 ...
PMID:[Developmental Gerstmann syndrome associated with cerebellar neoplasm. Report of a case and review of the literature]. 116 10

Eighty-seven children with histologically confirmed brain tumors were reviewed. Fifty-nine of the tumors were in the posterior fossa, 19 were cerebral gliomas, and nine were miscellaneous supratentorial tumors, including five craniopharyngiomas and two papillomas of the choroid plexus. In the posterior fossa there were 22 astrocytomas, 11 medulloblastomas, and ten ependymomas, indicating that half of the cerebellar tumors are benign. Of the patients with cerebellar astrocytomas, 15 are alive and 10 are probably cured. The cerebellar ependymomas have a very poor prognosis with only one long-term survivor and an average survival time of 14 months. The medulloblastoma group has only four survivors, and some of these are less than two years postoperative. Of 11 patients having cerebral astrocytoma, only three are leading satisfactory lives, three are dead, and five are handicapped to a significant degree. Of the eight patients with supratentorial ependymoma, all are dead with the longest survival being six years. It is emphasized that a benign cerebellar astrocytoma is the single most likely tumor in childhood, and many of these patients can be cured and survive without significant neurologic deficit.
 ...
PMID:Childhood brain tumors: a 15-year survey. 118 21


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>